Literature DB >> 23836503

Putting numbers to fluorescent guided surgery.

Eben L Rosenthal1, Kurt R Zinn.   

Abstract

Development of fluorescence standards may help improve the comparison between near-infrared fluorescence imaging devices, especially if they become commercially available. As translation of optical imaging for oncologic resections puts these techniques into the hands of more surgeons and operating personnel, improving the ability to compare results between devices and the simplicity of the device will be critical to improve adoption of this technology.

Mesh:

Substances:

Year:  2013        PMID: 23836503     DOI: 10.1007/s11307-013-0662-7

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  7 in total

1.  The need for performance standards in clinical translation and adoption of fluorescence molecular imaging.

Authors:  Eva M Sevick-Muraca; Banghe Zhu
Journal:  Med Phys       Date:  2013-04       Impact factor: 4.071

2.  Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma.

Authors:  Kristine E Day; Lauren N Beck; C Hope Heath; Conway C Huang; Kurt R Zinn; Eben L Rosenthal
Journal:  Cancer Biol Ther       Date:  2013-01-08       Impact factor: 4.742

3.  Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP.

Authors:  Banghe Zhu; Grace Wu; Holly Robinson; Nathaniel Wilganowski; Mary A Hall; Sukhen C Ghosh; Kenneth L Pinkston; Ali Azhdarinia; Barrett R Harvey; Eva M Sevick-Muraca
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

4.  Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.

Authors:  Kristine E Day; Lauren N Beck; Nicholas L Deep; Joy Kovar; Kurt R Zinn; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2013-04-24       Impact factor: 3.325

5.  Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice.

Authors:  C Hope Heath; Nicholas L Deep; Lauren N Beck; Kristine E Day; Larissa Sweeny; Kurt R Zinn; Conway C Huang; Eben L Rosenthal
Journal:  Otolaryngol Head Neck Surg       Date:  2013-03-22       Impact factor: 3.497

Review 6.  Optical image-guided surgery--where do we stand?

Authors:  Stijn Keereweer; Jeroen D F Kerrebijn; Pieter B A A van Driel; Bangwen Xie; Eric L Kaijzel; Thomas J A Snoeks; Ivo Que; Merlijn Hutteman; Joost R van der Vorst; J Sven D Mieog; Alexander L Vahrmeijer; Cornelis J H van de Velde; Robert J Baatenburg de Jong; Clemens W G M Löwik
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

7.  Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets.

Authors:  Ruth Cohen; Marieke A Stammes; Inge Hc de Roos; Marijke Stigter-van Walsum; Gerard Wm Visser; Guus Ams van Dongen
Journal:  EJNMMI Res       Date:  2011-12-01       Impact factor: 3.138

  7 in total
  8 in total

1.  A ratiometric threshold for determining presence of cancer during fluorescence-guided surgery.

Authors:  Jason M Warram; Esther de Boer; Lindsay S Moore; Cecelia E Schmalbach; Kirk P Withrow; William R Carroll; Joshua S Richman; Anthony B Morlandt; Margaret Brandwein-Gensler; Eben L Rosenthal
Journal:  J Surg Oncol       Date:  2015-06-12       Impact factor: 3.454

2.  Label-free hyperspectral imaging and quantification methods for surgical margin assessment of tissue specimens of cancer patients.

Authors:  Baowei Fei; Martin T Halicek; Xu Wang; Hongzheng Zhang; James V Little; Kelly R Magliocca; Mihir Patel; Christopher C Griffith; Mark W El-Deiry; Amy Y Chen
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2017-07

3.  Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).

Authors:  Yukihiko Hiroshima; Ali Maawy; Yong Zhang; Takashi Murakami; Masashi Momiyama; Ryutaro Mori; Ryusei Matsuyama; Takashi Chishima; Kuniya Tanaka; Yasushi Ichikawa; Itaru Endo; Robert M Hoffman; Michael Bouvet
Journal:  Pancreatology       Date:  2015-03-07       Impact factor: 3.996

4.  Tumor margin assessment of surgical tissue specimen of cancer patients using label-free hyperspectral imaging.

Authors:  Baowei Fei; Guolan Lu; Xu Wang; Hongzheng Zhang; James V Little; Kelly R Magliocca; Amy Y Chen
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-02-14

5.  Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.

Authors:  Yukihiko Hiroshima; Ali Maawy; Yong Zhang; Takashi Murakami; Masashi Momiyama; Ryutaro Mori; Ryusei Matsuyama; Matthew H G Katz; Jason B Fleming; Takashi Chishima; Kuniya Tanaka; Yasushi Ichikawa; Itaru Endo; Robert M Hoffman; Michael Bouvet
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

6.  Label-free reflectance hyperspectral imaging for tumor margin assessment: a pilot study on surgical specimens of cancer patients.

Authors:  Baowei Fei; Guolan Lu; Xu Wang; Hongzheng Zhang; James V Little; Mihir R Patel; Christopher C Griffith; Mark W El-Diery; Amy Y Chen
Journal:  J Biomed Opt       Date:  2017-08       Impact factor: 3.170

Review 7.  Perspective review of what is needed for molecular-specific fluorescence-guided surgery.

Authors:  Brian W Pogue; Eben L Rosenthal; Samuel Achilefu; Gooitzen M van Dam
Journal:  J Biomed Opt       Date:  2018-10       Impact factor: 3.170

Review 8.  The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review.

Authors:  Michael A Turner; Thinzar M Lwin; Siamak Amirfakhri; Hiroto Nishino; Robert M Hoffman; Paul J Yazaki; Michael Bouvet
Journal:  Biomolecules       Date:  2021-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.